Trump moves to require lower drug prices in Medicare

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

The NIH director did the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya do any pull-ups. And you can decide what you think of those push-ups. Send news tips and workout advice to [email protected] or John_Wilkerson.07 on Signal. I’ll see you again in the new year. This newsletter is taking a break for the holidays.

Trump’s favorite drug pricing policy

Since his first term, Trump has promised to lower U.S. drug prices to levels charged in other rich countries. On Friday, the administration announced most-favored nation deals with nine more drugmakers. Then CMS proposed two mandatory MFN pilot programs in Medicare.